Meta-analysis: Efficacy of bovine lactoferrin in Helicobacter pylori eradication

Alimentary Pharmacology and Therapeutics

Volumn 29, Issue 7, 2009, Pages 720-730

  Sachdeva, A ^a   Nagpal, J ^a  

^a SITARAM BHARTIA INSTITUTE OF SCIENCE AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BENZIMIDAZOLE; CLARITHROMYCIN; GLYCOPROTEIN; LACTOFERRIN; PROTON PUMP INHIBITOR; RANITIDINE BISMUTH CITRATE; TINIDAZOLE;

ABDOMINAL PAIN; ALLERGY; ANTIBACTERIAL ACTIVITY; ARTICLE; ATTRIBUTABLE RISK; CLINICAL TRIAL; CONFIDENCE INTERVAL; COW; DATA BASE; DIAGNOSTIC TEST; DIARRHEA; DRUG BINDING; DRUG EFFICACY; DRUG INHIBITION; DRUG MECHANISM; DRUG SAFETY; ERADICATION THERAPY; FECES; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; SIDE EFFECT; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; DIETARY SUPPLEMENTS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LACTOFERRIN; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 61849150931     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2009.03934.x     Document Type: Article

References (49)

1. Go MF. Review article: natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther 2002 16 (Suppl. 1 3 15.
2. Kadayifci A, Buyukhatipoglu H, Cemil Savas M, Simsek I. Eradication of Helicobacter pylori with triple therapy: an epidemiologic analysis of trends in Turkey over 10 years. Clin Ther 2006 28 : 1960 6.
3. Egan BJ, Katicic M, O'Connor HJ, O'Morain CA. Treatment of Helicobacter pylori. Helicobacter 2007 12 : 31 7.
4. Malfertheiner P. Compliance, adverse events and antibiotic resistance in Helicobacter pylori treatment. Scand J Gastroenterol Suppl 1993 196 : 34 7.
5. Opekun AR, Yeh CW, Opekun JL, Graham DY. In vivo tests of natural therapy, Tibetan yogurt or fresh broccoli, for Helicobacter pylori infection. Methods Find Exp Clin Pharmacol 2005 27 : 327 9.
6. Horie K, Horie N, Abdou AM, et al. Suppressive effect of functional drinking yogurt containing specific egg yolk immunoglobulin on Helicobacter pylori in humans. J Dairy Sci 2004 87 : 4073 9.
7. Yamazaki N, Yamuchi K, Kawase K, Hayasawa H, Nakao K, Imoto I. Antibacterial effects of lactoferrin and a pepsin-generated lactoferrin peptide against Helicobacter pylori in vitro. J Infect Chemother 1997 3 : 85 9.
8. Wada T, Aiba Y, Shimizu K, Takagi A, Miwa T, Koga Y. The therapeutic effect of bovine lactoferrin in the host infected with Helicobacter pylori. Scand J Gastroenterol 1999 34 : 238 43.
9. Higgins JPT, Green S, eds. Assessment of study quality. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]; Section 6. In : The Cochrane Library, Issue 4. Chichester : John Wiley & Sons, 2006, 79 91.
10. Juni P, Altman DJ, Egger M. Assessing the quality of randomized controlled trials. In : Egger M, Smith GD, Altman DG, eds. Systematic Reviews in Health Care: Meta-Analysis in Context. London : BMJ Publishing, 2001 : 87 108.
11. Di Mario F, Aragona G, Dal Bò N, et al. Use of bovine lactoferrin for Helicobacter pylori eradication. Dig Liver Dis 2003 35 : 706 10.
12. Di Mario F, Aragona G, Dal Bò N, et al. Bovine lactoferrin for Helicobacter pylori eradication: an open, randomized, multicentre study [Article]. Aliment Pharmacol Ther 2006 23 : 1235 40.
13. Zullo A, De Francesco V, Scaccianoce G, et al. Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomised, multicentre study. Dig Liver Dis 2005 37 : 496 500.
14. Tursi A, Elisei W, Brandimarte G, Giorgetti GM, Modeo ME, Aiello F. Effect of lactoferrin supplementation on the effectiveness and tolerability of a 7-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infection. Med Sci Monit 2007 13 : CR187 90.
15. Okuda M, Nakazawa T, Yamauchi K, et al. Bovine lactoferrin is effective to suppress Helicobacter pylori colonization in the human stomach: a randomized, double-blind, placebo-controlled study. J Infect Chemother 2005 11 : 265 9.
16. Cha n FK, Wong VW. Bovine lactoferrin added to triple therapy increased Helicobacter pylori eradication rate. ACP J Club 2006 145 : 49.
17. The addition of lactoferrin and probiotics to standard triple therapy may be beneficial in patients with Helicobacter pylori infections. Inpharma Wkly 2007 1592 : 10.
18. Di Mario F, Aragona G, Dal Bò N, et al. Bovine lactoferrin for Helicobacter pylori eradication: an open, randomized, multicentre study. ACP J Club 2006 145 : 49.
19. Adding bovine lactoferrin to triple therapy in patients with Helicobacter pylori infection increases eradication rates. Inpharma Wkly 2006 1540 : 12. http://inpharma.adisonline.com.
20. Addition of bovine lactoferrin improves H. pylori eradication. Inpharma Wkly 2003 1389 : 10. http://inpharma.adisonline.com.
21. Imoto I, Okuda M, Nakazawa T, et al. Suppressive effect of bovine lactoferrin against Helicobacter pylori. Helicobacter 2004 9 : 576 7.
22. Di Mario F, Dal Bò N, Aragona G, et al. Efficacy of bovine lactoferrin for Helicobacter pylori eradication: results of a multicenter study. Helicobacter 2004 9 : 568.
23. Aragona G, Di Mario F, Cavallaro LG, et al. Lactoferrin in a 1-week triple therapy for eradication of H. pylori. Helicobacter 2003 8 : 463.
24. Di Mario F, Aragona G, Bò ND, et al. Use of lactoferrin for Helicobacter pylori eradication: preliminary results. J Clin Gastroenterol 2003 36 : 396 8.
25. Zullo A, Lorenzetti R, Hassan C. A quintuple therapy for H. pylori eradication. Am J Gastroenterol 2007 102 : 2601.
26. Meyer JM. Use of lactoferrin for Helicobacter pylori eradication. J Clin Gastroenterol 2003 36 : 384 5.
27. King JC Jr., Cummings GE, Guo N, et al. A double-blind, placebo-controlled, pilot study of bovine lactoferrin supplementation in bottle-fed infants. J Pediatr Gastroenterol Nutr 2007 44 : 245 51.
28. Zullo A, De Francesco V, Scaccianoce G, Manes G, Efrati C, Hassan C. Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: a multicentre study. Dig Liver Dis 2007 39 : 806 10.
29. Di Mario F, Dal Bò N, Aragona G, et al. Bovine lactoferrin as rescue treatment for Helicobacter pylori infection: results of a multicenter study. Helicobacter 2004 9 : 569 70.
30. De Bortoli N. Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics. Am J Gastroenterol 2007 102 : 951 6.
31. Di Mario F, Cavallaro LG, Nouvenne A, et al. A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure? Helicobacter 2007 12 : 238 43.
32. Guttner Y, Windsor HM, Viiala CH, Marshall BJ. Human recombinant lactoferrin is ineffective in the treatment of human Helicobacter pylori infection. Aliment Pharmacol Ther 2003 17 : 125 9.
33. World Bank List of Economies. Downloaded from http://siteresources. worldbank.org/DATASTATISTICS/Resources/CLASS.XLS (accessed 14 March 2008).
34. Troost FJ, Steijns J, Saris WH, Brummer RJ. Gastric digestion of bovine lactoferrin in vivo in adults. J Nutr 2001 131 : 2101 4.
35. Dial EJ, Hall LR, Serna H, Romero JJ, Fox JG, Lichtenberger LM. Antibiotic properties of bovine lactoferrin on Helicobacter pylori. Dig Dis Sci 1998 43 : 2750 6.
36. Brock J. Lactoferrin: a multifunctional immunoregulatory protein? Immunol Today 1995 16 : 417 9.
37. Mann DM, Romm E, Migliorini M. Delineation of the glycosaminoglycan- binding site in the human inflammatory response protein lactoferrin. J Biol Chem 1994 269 : 23661 7.
38. Zhang GH, Mann DM, Tsai CM. Neutralization of endotoxin in vitro and in vivo by a human lactoferrin-derived peptide. Infect Immun 1999 67 : 1353 8.
39. Cole AM, Dewan P, Ganz T. Innate antimicrobial activity of nasal secretions. Infect Immun 1999 67 : 3267 75.
40. Jones EM, Smart A, Bloomberg G, Burgess L, Millar MR. Lactoferricin, a new antimicrobial peptide. J Appl Bacteriol 1994 77 : 208 14.
41. Tong JL, Ran ZH, Shen J, Zhang CX, Xiao SD. Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2007 25 : 155 68.
42. Guo JB, Yang PF, Wang MT, et al. The application of clostridium to the eradication of Helicobacter pylori. Chin J Celiopathy 2004 4 : 163 5.
43. Cao YJ, Qu CM, Yuan Q, et al. Control of intestinal flora alteration induced by eradication therapy of Helicobacter pylori infection in the elders. Chin J Gastroenterol Hepatol 2005 14 : 195 9.
44. Nista EC, Candelli M, Cremonini F, et al. Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. Aliment Pharmacol Ther 2004 20 : 1181 8.
45. Armuzzi A, Cremonini F, Bartolozzi F, et al. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2001 15 : 163 9.
46. Armuzzi A, Cremonini F, Ojetti V, et al. Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study. Digestion 2001 63 : 1 7.
47. Cremonini F, Di Caro S, Covino M, et al. Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol 2002 97 : 2744 9.
48. Myllyluoma E, Veijola L, Ahlroos T, et al. Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy - a placebo-controlled, double-blind randomized pilot study. Aliment Pharmacol Ther 2005 21 : 1263 72.
49. Canducci F, Armuzzi A, Cremonini F, et al. A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol Ther 2000 14 : 1625 9.